Related Experiment Video
Updated: May 24, 2025

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
A New Light-Sensor System Affecting Cancer Cell Fate.
Silvia Buonvino1, Ilaria Arciero2, Stefano Moretti2
1Departmental Faculty of Medicine, UniCamillus - Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.
A novel riboflavin-phosphocholine-light system photopolymerizes lysozyme, impacting cancer cell fate and viability. This discovery offers potential for new photodynamic therapies targeting cancer cells.
Area of Science:
- Biochemistry
- Biophysics
- Oncology
Background:
- Riboflavin and phosphocholine are physiological molecules with known roles in cellular processes.
- Lysozyme is an enzyme found in various biological contexts, including immune responses.
- Cancer cells exhibit altered expression of molecules like phosphocholine and lysozyme.
Purpose of the Study:
- To investigate a novel photopolymerizing system involving riboflavin, phosphocholine, and light (RPL).
- To determine the effects of the RPL system on protein photopolymerization, specifically lysozyme (LYZ).
- To evaluate the impact of RPL treatment on cancer cell viability, morphology, and differentiation.
Main Methods:
- In vitro photopolymerization of lysozyme using the riboflavin-phosphocholine-light system.
- Treatment of 2D and 3D cancer cell cultures and nontumoral cells with the RPL system.
- Generation of riboflavin-phosphocholine hydrogels (RPHy and RPHy-LYZ) via light-emitting diode exposure.
- Assessment of cell viability, morphology, aggregation, and differentiation post-treatment.
Main Results:
- The RPL system successfully induced lysozyme photopolymerization in vitro.
- RPL treatment affected cancer cell viability and induced morphological changes and aggregation, dependent on LYZ presence.
- Cancer cell-cell interfaces with phosphocholine and LYZ showed vulnerability to RPL treatment.
- RPHy hydrogels promoted osteoblast-like transdifferentiation of cancer cells, while RPHy-LYZ induced cell death.
Conclusions:
- The RPL system demonstrates significant effects on cancer cell fate through lysozyme photopolymerization.
- Phosphocholine and lysozyme expression at cancer cell interfaces create a targetable vulnerability for photodynamic therapy.
- Generated hydrogels show potential for modulating cancer cell behavior, including transdifferentiation and cell death.
- This research opens avenues for selective cancer therapies utilizing physiological molecules and light activation.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Published on: July 7, 2016